Expert outlook: Addressing current trends and challenges in clinical research with mass spectrometry
contributed by Thermo Fisher Scientific |
The healthcare industry looks toward new solutions to provide better outcomes at lower costs. With more treatment decisions now based on clinical lab results, labs play an important supporting role. Lab tests include screening, detection, and confirmation of various analytes for drugs-ofabuse testing and drug monitoring research. In drugs-of-abuse testing, labs continue to see a rise in novel psychoactive substances (NPS).
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.